Ignite Creation Date:
2025-12-24 @ 3:25 PM
Ignite Modification Date:
2026-01-05 @ 5:55 PM
Study NCT ID:
NCT01020292
Status:
COMPLETED
Last Update Posted:
2019-04-12
First Post:
2009-11-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV Glioma
Sponsor:
Abramson Cancer Center at Penn Medicine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-04
Start Date Type:
None
Primary Completion Date:
2017-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-12
Completion Date Type:
ACTUAL
First Submit Date:
2009-11-23
First Submit QC Date:
None
Study First Post Date:
2009-11-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-04-10
Last Update Post Date:
2019-04-12
Last Update Post Date Type:
ACTUAL